This chapter reviews the formulation research, development, and characterization of a tumor-targeting daunorubicin liposome preparation with a long circulating half-life (DaunoXome®). The identification of liposome formulations capable of delivering their...
CITATION STYLE
Forssen, E. A., & Proffitt, R. T. (1998). Design and Development of Long Circulating Liposomal Daunorubicin for In Vivo Targeting of Solid Tumors: DaunoXome®. In Long Circulating Liposomes: Old Drugs, New Therapeutics (pp. 73–96). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-22115-0_6
Mendeley helps you to discover research relevant for your work.